Eurosurveillance banner




Announcements
Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Weekly Release  2007: Volume 12/ Issue 35 Article 2 Printer friendly version
Back to Table of Contents
Previous Next

Eurosurveillance, Volume 12, Issue 35, 30 August 2007
Articles

Citation style for this article: Bruun T, Loewer HL. Prevalence surveillance system of nosocomial infections in Norway. Euro Surveill. 2007;12(35):pii=3258. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3258

Prevalence surveillance system of nosocomial infections in Norway

T Bruun (tone.bruun@fhi.no), HL Loewer

Nasjonalt Folkehelseinstitutt (Norwegian Institute of Public Health), Oslo, Norway

In 1996, the Norwegian Ministry of Health issued regulations on the prevention of nosocomial infections (NIs). The regulations were revised in 2005 [1]. As part of the infection control programme, hospitals and long-term care facilities (LTCFs) are obliged to have a surveillance system for NIs in place and to report the results to the Norwegian Institute of Public Health (NIPH). NIPH coordinates the surveillance activities and publishes annual statistics.

NIPH received the first annual reports from two thirds of the hospitals in 1999. That year, surveillance reports from LTCFs were sent from only one of the 19 counties in Norway [2]. Separate surveillance protocols for either hospitals or LTCFs were developed in 2002, and at present all hospitals and around one third of the LTCFs participate every year.

Methods
The hospitals and LTCFs are invited to participate in two nationwide point-prevalence surveys each year. The system is compatible with the recommendations of the “Hospitals in Europe Link for Infection Control through Surveillance” (HELICS) cooperation project of the European Union.

NIPH collects information on the occurrence of the most common nosocomial infections [3]:

  • Urinary tract infections
  • Lower respiratory tract infections
  • Superficial and deep surgical site infections
  • Soft tissue skin infections (only in LTCFs)
  • Septicaemias (only in hospitals)
The case definitions are simplified versions of the definitions recommended by the Centers for Disease Control and Prevention (CDC). Patients who underwent surgery 30 days prior to the infection (or one year in the case of implant surgery) are also reported.

A paper version of the surveillance protocol was posted to all institutions in 2002 and 2004. Since autumn 2005, NIPH sends out an invitation by e-mail before every survey, In addition the protocol is available on the NIPH homepage (http://www.fhi.no).

On the day of the prevalence survey each ward or unit registers infections according to the protocol. The infection control personnel coordinate the data collection and report to NIPH either directly into the web-based surveillance tool or by mail or e-mail. Almost all hospitals report electronically. An increasing part of the LTCFs participate, this year it was two thirds. The reports that are received are summary data and contain no patient identification. Since 2007 all institutions can see their own prevalence data presented online and compare their results with the regional and national results. In addition, two seasonal and one annual summary report are published on the NIPH web site.

Results
The development of the prevalence of NIs at hospitals in Norway from 2002 to 2007 is shown in Figure 1. The NI prevalence has been stable in the last years, including the distribution of the different types of infection.

The development of the prevalence of NIs in LTCFs in Norway from 2002 to 2007 is shown in Figure 2. The surveys show that also in LTCFs, the prevalence over the years has been relatively stable.

Discussion
The prevalence surveys cannot replace the surveillance of the incidence of NIs. They give only snap-shot impressions of the infection status of the patients hospitalised on a certain day, and the results must be interpreted with caution, especially in small units. The results must be evaluated in connection with other available information and can then be useful to indicate the extent and distribution of NIs by type of department, size of health care institution and geographic location, show the development over time and indicate problems that may require more extensive investigation.

The web-based surveillance tool simplifies and secures the data registration at the hospitals and LTCFs as well as at the NIPH. In addition, it gives the institutions faster and easier access to the results.

References:
  1. Helsetilsynet. Forskrift av 2005-06-17 nr 610 om smittevern i helsetjenesten. [In Norwegian]. Helse- og omsorgsdepartementet. Available from: http://www.lovdata.no/cgi-wift/ldles?doc=/sf/sf/sf-20050617-0610.html
  2. Eriksen HM, Iversen BG, Stormark M. Årsrapporter om sykehusinfeksjoner ved norske sykehus i 1999 og 2000. [In Norwegian]. Statens institutt for folkehelse, Seksjon for forebyggende infeksjonsmedisin. Available from: http://www.fhi.no/artikler/?id=41781
  3. Norwegian Institute of Public Health. Surveillance of Communicable Diseases and Nosocomial Infections in Norway 2006. Available from: http://www.fhi.no/dav/3d326fd31e.pdf

back to top



Back to Table of Contents
Previous Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2007-2013. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.